Are we progressing in prostate cancer management?

Are we progressing in prostate cancer management?

Saved in:

Bibliographic Details
Main Authors:	Hiten RH. Patel, Reena Patel
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Asian Journal of Urology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388220300758
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of Advanced Prostate Cancer: Where Are We in 2019?
by: Fernando Sabino Marques Monteiro, et al.
Published: (2019-01-01)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
by: Parth Patel, et al.
Published: (2015-01-01)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024-09-01)

Urine Biomarkers for Prostate Cancer Diagnosis and Progression
by: Jeremy Clark, Rachel Hurst, Mark Simon Winterbone, Hardev Pandha, Antoinette Perry, Sophie McGrath, Richard Morgan, Adele E Connor, Asia C Jordan, Deirdre Winrow, Colin Cooper
Published: (2021-05-01)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025-05-01)

Metastatic Pancreatic Cancer: Are We Making Progress in Treatment?
by: Joanne Chiu, et al.
Published: (2012-01-01)

Pathological Assessment of Men with Grade Group 2 Prostate Cancer
by: Anika Jain, et al.
Published: (2025-07-01)

Scientific contribution of Turkey in prostate literature. Where are we? Where are we going?
by: Selahattin Çalışkan, et al.
Published: (2017-12-01)

Research progress of exosomes in the diagnosis and treatment of prostate cancer
by: Li-Ming MA, et al.
Published: (2021-04-01)

Current progress and questions in germline genetics of prostate cancer
by: William B. Isaacs, et al.
Published: (2019-01-01)

Research progress of tumor vaccines in the treatment of prostate cancer
by: Chen Zheng, et al.
Published: (2024-02-01)

The role of interleukin-8 in the development and progression of prostate cancer
by: Sheng WANG, et al.
Published: (2021-10-01)

The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer
by: Yeasin Ahamed, et al.
Published: (2025-08-01)

Focal Therapy in the Management of Prostate Cancer: An Emerging Approach for Localized Prostate Cancer
by: Takeo Nomura, et al.
Published: (2012-01-01)

UBC Mediated by SEPT6 Inhibited the Progression of Prostate Cancer
by: Ruochen Zhang, et al.
Published: (2021-01-01)

Environmental interpretation of the impact of vehicle emissions on prostate cancer progression
by: Bingzheng An, et al.
Published: (2025-07-01)

Research Progress of AR Gene Family in Prostate Cancer Therapy
by: Maham Khan
Published: (2024-10-01)

Research progress on mechanisms of endocrine therapy resistance in prostate cancer
by: QI Zihao, et al.
Published: (2025-04-01)

Post-acute asthma exacerbation care: are we following patients up timely or are we harming them?
by: Jayden Patel, et al.
Published: (2025-07-01)

The Role of Ayurveda in Prostate Cancer Management
by: Parnian Jabbari MD, et al.
Published: (2025-03-01)

The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review
by: Clare Chen, et al.
Published: (2025-05-01)

MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration—Where Are We Now?
by: Mariana Ferreira, et al.
Published: (2024-10-01)

Transcriptomic and functional analysis of triphenyl phosphate exposure in prostate cancer progression
by: Li Cai, et al.
Published: (2025-08-01)

The role of LKB1 in prostate cancer: implications for tumor progression and therapy
by: Yuwei Liang, et al.
Published: (2025-08-01)

Emerging implications of N6-methyladenosine in prostate cancer progression and treatment
by: Junyan Xu, et al.
Published: (2025-08-01)

The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
by: Jizhong Che, et al.
Published: (2025-03-01)

Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
by: Marco Bolis, et al.
Published: (2021-12-01)

Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer
by: Shaun Trecarten, et al.
Published: (2025-01-01)

Macrophages in prostate cancer: dual roles in tumor progression and immune evasion
by: Ruihong Liu, et al.
Published: (2025-06-01)

Orthobiologics in Foot and Ankle: Do We Have Enough Evidence?
by: Sandeep Patel, et al.
Published: (2024-09-01)

Can We Do Without Progress?
by: B.N. van Hulzen
Published: (2024-12-01)

Current Status of Cryoablation in Prostate Cancer Management
by: Jakub Karwacki, et al.
Published: (2025-07-01)

Management of High-Risk Localized Prostate Cancer
by: Ariel E. Marciscano, et al.
Published: (2012-01-01)

The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer
by: Eun-mi Yu, et al.
Published: (2024-09-01)

Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer
by: Jesal C. Patel, et al.
Published: (2013-01-01)

Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
by: Fidelis Charles Bugoye, et al.
Published: (2025-03-01)

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study
by: Pedro Costa, et al.
Published: (2025-08-01)

How Do We Identify and Manage Progressive CTD-ILD?-Update in Treatment and Guideline
by: Oliver Distler, et al.
Published: (2024-01-01)

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer
by: Yasutaka Yamada, et al.
Published: (2025-03-01)

Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer
by: Mengfei Yao, et al.
Published: (2025-02-01)